Allogene Therapeutics

ALLO
0.83871.41% ( +0.0117 )
已收盘: 11月13日 16:00:00 (美东)

股东

全部股东

股东类型

  • 机构投资者74.46%
  • 风投/私募12.84%
  • 公众及其他7.17%
  • 个人与内部人士5.53%

主要股东

主要股东 最新
股东
BlackRock, Inc.
6.70%2,321.17 万2.03%-693.52 万
Frazier Life Sciences Management, LP
6.48%2,244.67 万4.93%+1,865.00 万
Pfizer Venture Investments LLC
6.36%2,203.20 万0.02%+0
State Street Investment Management
4.71%1,632.62 万0.80%-269.96 万
Vanguard Capital Management, LLC
4.04%1,400.50 万0.77%+599.18 万
Sio Capital Management, LLC
3.85%1,332.34 万--+1,332.34 万
PRIMECAP Management Company
3.79%1,312.34 万0.36%+474.36 万
UBS Asset Management AG
3.09%1,070.43 万2.21%+766.59 万
FMR LLC
3.06%1,058.98 万0.42%-140.91 万
Citadel Advisors LLC
2.91%1,008.78 万0.14%+329.42 万
Two Sigma Investments, LP
2.25%778.43 万0.05%+240.89 万
Geode Capital Management, LLC
1.86%644.68 万0.18%-60.25 万
Arie BelldegrunCo-Founder & Executive Chairman
1.75%607.78 万0.73%+0
The Goldman Sachs Group, Inc.
1.73%599.40 万<0.01%+0
David ChangCo-Founder & Director
1.72%595.23 万0.71%+0
Candriam, Société En Commandite Par Actions
1.57%542.28 万0.31%+108.65 万
GordonMD Global Investments LP
1.53%529.80 万0.95%+386.80 万
Aberdeen Group Plc
1.52%525.97 万0.07%+25.79 万
Marshall Wace LLP
1.47%509.54 万0.06%+164.74 万
Millennium Management LLC
1.40%484.39 万0.04%+152.18 万